Guanglong Jiang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- Cancer-related gene regulation 4
- Glycosylation and Glycoproteins Research 2
- Oncology 11
- Cancer Treatment and Pharmacology 4
- Co-authors
- Yunlong Liu (28 shared papers)Meng Li (1 shared paper)Shijun Zhang (1 shared paper)Lijun Cheng (1 shared paper)Bryan P. Schneider (14 shared papers)Fei Shen (12 shared papers)Tao Lu (8 shared papers)Benlian Wang (5 shared papers)
- Journals
- Cancers (4 papers)Clinical Cancer Research (4 papers)Scientific Reports (3 papers)BMC Genomics (3 papers)Cancer Research (3 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Guanglong Jiang
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 232
- Oncology 312
- Molecular Biology 569
- Immunology 95
- Pulmonary and Respiratory Medicine 131
Countries citing papers authored by Guanglong Jiang
This map shows the geographic impact of Guanglong Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanglong Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanglong Jiang more than expected).
Fields of papers citing papers by Guanglong Jiang
This network shows the impact of papers produced by Guanglong Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanglong Jiang. The network helps show where Guanglong Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guanglong Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 165 | |
| 2 | 2016 | 162 | |
| 3 | 2017 | 80 | |
| 4 | 2014 | 67 | |
| 5 | 2016 | 67 | |
| 6 | 2017 | 57 | |
| 7 | 2019 | 54 | |
| 8 | 2020 | 51 | |
| 9 | 2013 | 47 | |
| 10 | 2020 | 34 | |
| 11 | 2017 | 30 | |
| 12 | 2016 | 30 | |
| 13 | 2011 | 23 | |
| 14 | 2019 | 21 | |
| 15 | 2020 | 20 | |
| 16 | 2020 | 20 | |
| 17 | 2021 | 19 | |
| 18 | 2019 | 17 | |
| 19 | 2023 | 15 | |
| 20 | 2020 | 15 |
About Guanglong Jiang
Guanglong Jiang is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Cardiology and Cardiovascular Medicine, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer-related gene regulation (4 papers), Cancer-related molecular mechanisms research (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), MicroRNA in disease regulation (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Cancer Research (232 citations), Oncology (312 citations), Molecular Biology (569 citations), Immunology (95 citations) and Pulmonary and Respiratory Medicine (131 citations). Guanglong Jiang has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Yunlong Liu, Meng Li, Shijun Zhang, Lijun Cheng, Bryan P. Schneider, Fei Shen, Tao Lu, Benlian Wang, Wei Han and Kathy D. Miller. Their work appears in journals such as Cancers, Clinical Cancer Research, Scientific Reports, BMC Genomics and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.